BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33822354)

  • 1. Outcomes of methotrexate-associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs.
    Harada T; Iwasaki H; Muta T; Urata S; Sakamoto A; Kohno K; Takase K; Miyamura T; Sawabe T; Asaoku H; Oryoji K; Fujisaki T; Mori Y; Yoshimoto G; Ayano M; Mitoma H; Miyamoto T; Niiro H; Yamamoto H; Oshiro Y; Miyoshi H; Ohshima K; Takeshita M; Akashi K; Kato K
    Br J Haematol; 2021 Jul; 194(1):101-110. PubMed ID: 33822354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.
    Nakano K; Saito K; Nawata A; Hanami K; Kubo S; Miyagawa I; Fujino Y; Nakayamada S; Tanaka Y
    Mod Rheumatol; 2021 Jan; 31(1):94-100. PubMed ID: 32159414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study.
    Nakano K; Tanaka Y; Saito K; Kaneko Y; Saito S; Tanaka M; Saito R; Fujii T; Kuramoto N; Sugimoto N; Takada H; Harigai M; Sasaki S; Suzuki Y
    Mod Rheumatol; 2022 Jan; 32(1):41-49. PubMed ID: 33164614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1 expression is associated with the spontaneous regression of patients with methotrexate-associated lymphoproliferative disorders.
    Gion Y; Doi M; Nishimura Y; Ikeda T; Filiz Nishimura M; Sakamoto M; Egusa Y; Nishikori A; Fujita A; Iwaki N; Nakamura N; Yoshino T; Sato Y
    Cancer Med; 2022 Jan; 11(2):417-432. PubMed ID: 34842351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate-associated Hodgkin Lymphoma in a Patient with Rheumatoid Arthritis Successfully Treated with Brentuximab Vedotin in Combination with Doxorubicin, Vinblastine, and Dacarbazine (BV+AVD).
    Sekiguchi Y; Iizuka H; Takizawa H; Sugimoto K; Sakajiri S; Inano T; Fukuda Y; Shirane S; Hamano Y; Tomita S; Izumi H; Okubo M; Nakamura N; Sawada T; Sekiguchi N; Noguchi M
    Intern Med; 2020 Sep; 59(17):2165-2171. PubMed ID: 32461524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis.
    Tanaka K; Ichikawa A; Umezawa N; Yamamoto K; Yoshifuji K; Okada K; Nogami A; Umezawa Y; Nagao T; Sakashita C; Mori T; Tohda S; Koike R; Yasuda S; Yamamoto M
    Cancer Sci; 2023 Sep; 114(9):3719-3727. PubMed ID: 37365854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis-Associated Lymphoproliferative Disorders.
    Hoshida Y; Tsujii A; Ohshima S; Saeki Y; Yagita M; Miyamura T; Katayama M; Kawasaki T; Hiramatsu Y; Oshima H; Murayama T; Higa S; Kuraoka K; Hirano F; Ichikawa K; Kurosawa M; Suzuki H; Chiba N; Sugiyama T; Minami Y; Niino H; Ihata A; Saito I; Mitsuo A; Maejima T; Kawashima A; Tsutani H; Takahi K; Kasai T; Shinno Y; Tachiyama Y; Teramoto N; Taguchi K; Naito S; Yoshizawa S; Ito M; Suenaga Y; Mori S; Nagakura S; Yoshikawa N; Nomoto M; Ueda A; Nagaoka S; Tsuura Y; Setoguchi K; Sugii S; Abe A; Sugaya T; Sugahara H; Fujita S; Kunugiza Y; Iizuka N; Yoshihara R; Yabe H; Fujisaki T; Morii E; Takeshita M; Sato M; Saito K; Matsui K; Tomita Y; Furukawa H; Tohma S
    Arthritis Rheumatol; 2024 Jun; 76(6):869-881. PubMed ID: 38272827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders.
    Tokuhira M; Tanaka Y; Takahashi Y; Kimura Y; Tomikawa T; Anan T; Watanabe J; Sagawa M; Higashi M; Momose S; Amano K; Tabayashi T; Nakaseko R; Tamaru JI; Kizaki M
    J Clin Exp Hematop; 2020 Jun; 60(2):41-50. PubMed ID: 32404570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Notch1 protein expression in methotrexate-associated lymphoproliferative disorders.
    Okatani T; Nishimura MF; Egusa Y; Yoshida S; Nishimura Y; Nishikori A; Yoshino T; Yamamoto H; Sato Y
    J Clin Exp Hematop; 2024 Mar; 64(1):1-9. PubMed ID: 38281745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of incident cardiovascular events with disease-modifying anti-rheumatic drugs among adults with rheumatoid arthritis: a nested case-control study.
    Huang Y; Agarwal SK; Chatterjee S; Chen H; Johnson ML; Aparasu RR
    Clin Rheumatol; 2024 Jan; 43(1):103-116. PubMed ID: 37540382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate-associated lymphoproliferative disorder with an osteolytic vertebral lesion in an elderly patient with rheumatoid arthritis: A case report.
    Hirata C; Kenzaka T; Akita H
    J Clin Pharm Ther; 2021 Aug; 46(4):1178-1181. PubMed ID: 33768586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of bilateral methotrexate-associated diffuse large B-cell lymphomas of the breasts with unique clinical presentation and outcome.
    Tomita M; Oura S; Nishiguchi H; Makimoto S
    Breast Cancer; 2020 Sep; 27(5):1038-1043. PubMed ID: 32361905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases.
    Kaji D; Kusakabe M; Sakata-Yanagimoto M; Makishima K; Suehara Y; Hattori K; Ota Y; Mitsuki T; Yuasa M; Kageyama K; Taya Y; Nishida A; Ishiwata K; Takagi S; Yamamoto H; Asano-Mori Y; Ubara Y; Izutsu K; Uchida N; Wake A; Taniguchi S; Yamamoto G; Chiba S
    Br J Haematol; 2021 Nov; 195(4):585-594. PubMed ID: 34558064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of methotrexate use and lymphoproliferative disorder in patients with rheumatoid arthritis: Results from a Japanese multi-institutional retrospective study.
    Honda S; Sakai R; Inoue E; Majima M; Konda N; Takada H; Kihara M; Yajima N; Nanki T; Yamamoto K; Takeuchi T; Harigai M
    Mod Rheumatol; 2022 Jan; 32(1):16-23. PubMed ID: 33428479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the┬áliterature.
    Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
    J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Most Appropriate Conventional Disease-Modifying Antirheumatic Drug to Combine With Different Advanced Therapies in Rheumatoid Arthritis: A Systematic Literature Review With Meta-Analysis.
    Decarriere G; Barnetche T; Combe B; Gaujoux-Viala C; Lukas C; Morel J; Daien C
    Arthritis Care Res (Hoboken); 2021 Jun; 73(6):873-884. PubMed ID: 32216091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic lymphoproliferative disorder arising in a rheumatoid arthritis patient, presenting as fibrin-associated large B-cell lymphoma-like lesions in aortic and mitral valves.
    Tsujii H; Nakayama R; Funakoshi S; Tsuji S; Haga H; Ono K
    Pathol Int; 2024 May; 74(5):285-291. PubMed ID: 38563592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methotrexate-related lymphoproliferative disease showing different histological findings at recurrence].
    Kato T; Imaizumi Y; Itonaga H; Sato S; Ando K; Sawayama Y; Ichinose K; Miyoshi H; Ohshima K; Miyazaki Y
    Rinsho Ketsueki; 2023; 64(2):97-101. PubMed ID: 36990739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature.
    He J; Williamson L; Cai K; Wong P; Sturgess A; Taper J; Manolios N
    Intern Med J; 2022 Oct; 52(10):1717-1723. PubMed ID: 34028145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic correlations of diffuse large B-cell lymphoma in rheumatoid arthritis patients treated with methotrexate.
    Niitsu N; Okamoto M; Nakamine H; Hirano M
    Cancer Sci; 2010 May; 101(5):1309-13. PubMed ID: 20210795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.